Emerson (EMR) PT Raised to $116 at UBS
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $163.79 +0.38%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
UBS analyst Markus Mittermaier raised the price target on Emerson (NYSE: EMR) to $116.00 (from $113.00) while maintaining a Buy rating.
You May Also Be Interested In
- Emerson (EMR) PT Raised to $186 at Bernstein SocGen Group
- Broadridge Financial (BR) PT Raised to $180 at UBS, Neutral Rating Maintained
- BP awards Emerson a contract for Shah Deniz offshore automation
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
